Since selective deletion of CD1d in B cells in mice with PBC significantly impaired the therapeutic activity of αGalCer/CD1d-NP treatment, it is likely that these LiNKT-B-cell interactions play critical roles not only in Breg cell formation but also in LiNKTR1 cell activation and homeostasis. The gene discussed is CD1D; the disease is primary biliary cholangitis.